Recent Finacing
Recent Raise
ELARA Pharmaceuticals is a Heidelberg-based biopharma, spun out of EMBL, developing hypoxia-inducible factor (HIF) antagonist drugs for preclinical oncology programs advancing toward clinical readiness.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
